Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension.
暂无分享,去创建一个
[1] N. Vaziri,et al. Intra-Renal Angiotensin II/AT1 Receptor, Oxidative Stress, Inflammation, and Progressive Injury in Renal Mass Reduction , 2007, Journal of Pharmacology and Experimental Therapeutics.
[2] N. Tomita,et al. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats , 2010, Diabetologia.
[3] R. Blantz,et al. Glomerular Hyperfiltration and the Salt Paradox in Early Type 1 Diabetes Mellitus: A Tubulo-Centric View , 2003 .
[4] J. Dubernard,et al. [The kidney]. , 2011, Bulletin de l'Academie nationale de medecine.
[5] P. Codoñer-Franch,et al. Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus , 2009, Pediatric Nephrology.
[6] A. Dominiczak,et al. Glomerular hyperfiltration: a new marker of metabolic risk. , 2007, Kidney international.
[7] H. Parving,et al. Effects of acetazolamide on kidney function in Type 1 (insulin-dependent) diabetic patients with diabetic nephropathy , 1988, Diabetologia.
[8] N. Hamajima,et al. Glomerular hyperfiltration in prediabetes and prehypertension. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] D. Gaudet,et al. Predictors of Target Organ Damage in Hypertensive Blacks and Whites , 2001, Hypertension.
[10] J. Satriano. Kidney growth, hypertrophy and the unifying mechanism of diabetic complications , 2007, Amino Acids.
[11] E. Tremoli,et al. Cytokines present in smokers' serum interact with smoke components to enhance endothelial dysfunction. , 2011, Cardiovascular research.
[12] M. G. Cogan,et al. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. , 1990, Hypertension.
[13] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[14] B. Brenner,et al. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. , 2000, Kidney international.
[15] V. Campese,et al. Abnormal Renal Hemodynamics in Black Salt-Sensitive Patients With Hypertension , 1991, Hypertension.
[16] F. Kaskel,et al. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. , 2006, Advances in chronic kidney disease.
[17] T. Ichiki. Collaboration between smokers and tobacco in endothelial dysfunction. , 2011, Cardiovascular research.
[18] R. Schmieder,et al. Glomerular hyperfiltration indicates early target organ damage in essential hypertension. , 1990, JAMA.
[19] P. Savage,et al. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. , 1989, The New England journal of medicine.
[20] G. Luippold,et al. Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] T. Weinstein,et al. The effects of weight loss on renal function in patients with severe obesity. , 2003, Journal of the American Society of Nephrology : JASN.
[22] H. Rüddel,et al. Predictors for hypertensive nephropathy: results of a 6‐year follow‐up study in essential hypertension , 1995, Journal of hypertension.
[23] R. MacIsaac,et al. Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate , 2005, Diabetologia.
[24] C. Zoccali,et al. Does high salt intake cause hyperfiltration in patients with essential hypertension? , 1996, Journal of human hypertension.
[25] A. Luke,et al. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] L. Lerman,et al. Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. , 2011, American journal of physiology. Renal physiology.
[27] K. K. Sato,et al. Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[28] P. Piazolo,et al. Progressive renal failure in a remnant kidney. , 1986, British medical journal.
[29] C. Zoccali. Overweight, obesity and metabolic alterations in chronic kidney disease. , 2009, Prilozi.
[30] A. Dominiczak,et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.
[31] F. Ruschitzka,et al. Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension. , 2001, Journal of the American Society of Nephrology : JASN.
[32] D. Fernandes,et al. Tobacco Smoke Induces Ventricular Remodeling Associated with an Increase in NADPH Oxidase Activity , 2011, Cellular Physiology and Biochemistry.
[33] P. Palatini,et al. Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. , 2006, Kidney international.
[34] S. Nielsen,et al. Systolic Blood Pressure Relates to the Rate of Decline of Glomerular Filtration Rate in Type II Diabetes , 1993, Diabetes Care.
[35] M. Burnier,et al. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] A. Fabris,et al. Clinical features of patients with solitary kidneys. , 1986, Nephron.
[37] B. Brenner,et al. The hyperfiltration theory: a paradigm shift in nephrology. , 1996, Kidney international.
[38] B. Brenner,et al. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[39] J. Scholey,et al. Renal Hyperfiltration and Arterial Stiffness in Humans With Uncomplicated Type 1 Diabetes , 2010, Diabetes Care.
[40] B. Brenner,et al. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. , 1986, The Journal of clinical investigation.
[41] G. Eknoyan,et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.
[42] G. Remuzzi,et al. ACE inhibition is renoprotective among obese patients with proteinuria. , 2011, Journal of the American Society of Nephrology : JASN.
[43] G. Dahlquist,et al. RENAL FUNCTION IN RELATION TO METABOLIC CONTROL IN CHILDREN WITH DIABETES OF DIFFERENT DURATION , 1983, Acta paediatrica Scandinavica.
[44] L. Solomon,et al. Progressive renal failure in a remnant kidney. , 1985, British medical journal.
[45] S. Nielsen,et al. The clinical course of renal function in NIDDM patients with normo‐ and microalbuminuria , 1997, Journal of internal medicine.
[46] I. Njølstad,et al. Impaired Fasting Glucose Is Associated With Renal Hyperfiltration in the General Population , 2011, Diabetes Care.
[47] F C Luft,et al. Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension. , 1997, Journal of the American Society of Nephrology : JASN.
[48] M. Hargreaves,et al. Glomerular hyperfiltration in insulin-dependent diabetes mellitus: no evidence for enhanced activity of the renin-angiotensin-aldosterone system. , 1991, The Journal of diabetic complications.
[49] N. Kurtzman,et al. Chapter III Role of Hyperfiltration in the Pathogenesis of Diabetic Nephropathy , 2011 .
[50] U. Gafter,et al. Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[51] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[52] R. Bilous,et al. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis , 2009, Diabetologia.
[53] John E Hall,et al. The kidney, hypertension, and obesity. , 2003, Hypertension.
[54] D. Dunger,et al. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. , 2005, Kidney international.
[55] Da‐hong Wang,et al. C-reactive protein is associated with cigarette smoking-induced hyperfiltration and proteinuria in an apparently healthy population , 2010, Hypertension Research.
[56] E. Sochett,et al. Evolution of Renal Hyperfiltration and Arterial Stiffness From Adolescence Into Early Adulthood in Type 1 Diabetes , 2011, Diabetes Care.
[57] G. Remuzzi,et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. , 2011, Journal of the American Society of Nephrology : JASN.
[58] P. Palatini,et al. Cystatin C as Predictor of Microalbuminuria in the Early Stage of Hypertension , 2009, Nephron Clinical Practice.